Park Ha Biological (BYAH) announced on July 6, 2026, the successful approval and completion of registration procedures to open its Amazon North America store, marking a key milestone in its global expansion strategy. Despite this positive development, the stock is trading at $0.67 (-5.78%) in pre-market, extending a sharp multi-day decline from its June 25 high of $1.22. The price movement appears driven by profit-taking and broader market sentiment following a volatile June rally.
🔴 BYAH Plunges 5.8% Despite Amazon North America Store Approval
Park Ha Biological Technology Co., Ltd.
Related News
BYAH
🔴 Park Ha Biological Technology is trading 5.67% down today amid risk-off selling
BYAH
🟢 Park Ha Biological Technology is trading 7.27% up today
BYAH
🟢 Park Ha Biological Technology is trading 9.56% up in pre-market amid stronger biotechnology sentiment
BYAH
🟢 Park Ha Biological Technology is trading 11.6% up today as biotech sentiment strengthens
BYAH